Delivery Order SPE2DB22D3501-SPE2DB25FXF28
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,514.00 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Timolol 0.25% Gel-Solution 5ML. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Timolol 0.5% Gel-Solution 5ML. The contract has a potential value of $3,080.77 and a period of performance through January 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with a potential value of up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of Timolol 0.25% gel-solution 5ml, a pharmaceutical product, to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $2,148.12 and an ultimate completion date of September 17, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at up to $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Timolol 0.5% eye drops in 5ml quantities, with a ceiling value of $1,420.89. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $7,648 to Amerisourcebergen Drug Corporation to supply timolol gel solution. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning September 6 and concluding September 7 of 2023. The Defense Logistics Agency functions to support America's armed forces by procuring their...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific contract award is for $1,458.14 and covers the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. This contract has no set-aside designation, indicating open competition. AmerisourceBergen, a major...
- The Defense Logistics Agency Troop Support Medical awarded a $9,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561697174 timolol 0.25% gel-solution 5ml. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order runs from August 3 to August 4, 2023, with no subcontractors involved. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring pharmaceuticals and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide a pharmaceutical product, Timolol 0.5% GFS Gel-Solution 5ML, with a potential value of $1,224.59 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Timolol 0.5% Gel-Solution (5ml) to support government healthcare programs. The $14,197.90 delivery order was issued by the Defense Logistics Agency (DLA) and has a January 2022 completion date. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF28Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a ceiling value of $1,217.05. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs, consistent with the company's ongoing role as a critical vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's comprehensive federal pharmaceutical portfolio spans multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies, positioning the company as a key provider within the Defense Logistics Agency's medical supply chain serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/8/25 |